How to Use QUADAS-2 to Assess Bias in Diagnostic Accuracy Studies

Introduction

Diagnostic accuracy studies are essential for understanding whether a test can correctly distinguish between those with and without a condition. However, the methodological quality of such studies can vary widely—and poor design can significantly bias the results.

To address this, researchers use QUADAS-2, a structured tool developed to assess the risk of bias and applicability concerns in primary diagnostic accuracy studies. Unlike a checklist that produces a summary score, QUADAS-2 guides critical appraisal using a domain-based judgment system.

In this article, we’ll walk through the structure and application of QUADAS-2 in depth, complete with illustrative examples to reinforce your mastery of each domain.

---

🧩 The Four Phases of QUADAS-2 Assessment

Before the actual appraisal begins, QUADAS-2 involves a preparatory sequence:

1. Define the Review Question

A clear systematic review question should specify:

• Patients/population

• Index test(s)

• Reference standard

• Target condition

• Intended use (diagnosis, triage, screening)
  

2. Tailor the Tool to the Review

• Customize signaling questions for each domain based on the topic.

• Define disease spectrum and thresholds where applicable.
  

3. Review the Study’s Flow Diagram

• Ensure clarity on recruitment, testing sequence, and patient inclusion.

• Construct a flow diagram if one is missing.
  

4. Judge Bias and Applicability

• Rate each domain as Low, High, or Unclear for:

  • Risk of Bias

  • Applicability Concerns
    

---

🧱 The Four Domains of QUADAS-2

Each domain addresses a critical aspect of study design and execution.

---

🔍 Domain 1: Patient Selection

Risk of Bias:

Could the way patients were selected introduce bias?

• Yes, if using case-control designs (especially if selecting extreme cases).

• Yes, if excluding many eligible patients without a clear rationale.

Applicability Concern:

Do the included patients match those in your intended clinical setting?

Signaling Questions:

1. Was a consecutive or random sample used?

2. Was a case-control design avoided?

3. Were inappropriate exclusions avoided?

Clinical Example:

Evaluating a diagnostic test for early Alzheimer's disease using only patients from a neurology referral center excludes the broader spectrum seen in primary care—this introduces both selection and spectrum bias.

---

🧪 Domain 2: Index Test

Risk of Bias:

Could the conduct or interpretation of the index test introduce bias?

• Yes, if the index test reader knew the reference result (review bias).

• Yes, if the test threshold was chosen after data analysis (overfitting).

Applicability Concern:

Is the test technique and interpretation generalizable?

Signaling Questions:

1. Was the test interpreted blinded to the reference standard?

2. Was the positivity threshold pre-specified?

Clinical Example:

A radiologist assessing CT scans for pulmonary embolism should not know D-dimer results or clinical gestalt. If the threshold for “positive” is derived from ROC post hoc, accuracy is likely inflated.

---

🧬 Domain 3: Reference Standard

Risk of Bias:

Is the reference standard itself reliable in diagnosing the condition?

• Bias may occur with imperfect gold standards (e.g., clinical diagnosis instead of biopsy).

• Bias also arises if the reference test is interpreted with knowledge of the index test.

Applicability Concern:

Does the definition of the target condition match what your question needs?

Signaling Questions:

1. Is the reference likely to correctly classify the condition?

2. Was it interpreted blind to the index test?

Clinical Example:

Using physician discharge diagnosis to confirm pneumonia status introduces incorporation bias if the physician relied on the chest X-ray (the index test) to make the diagnosis.

---

🕓 Domain 4: Flow and Timing

Risk of Bias:

Could the timing and sequence of tests or patient inclusion bias the results?

• Bias arises if not all patients receive both tests.

• Long delays between index and reference test can alter disease status.

Signaling Questions:

1. Was the interval between tests appropriate?

2. Did all patients receive the same reference test?

3. Were all patients included in the analysis?

Clinical Example:

If patients with negative rapid troponins are not referred for angiography, this can result in partial verification bias—the diagnostic accuracy of troponin is then misrepresented.

---

⚖️ Interpreting Judgments

Each domain is rated:

• Low risk: All signaling questions answered “yes”

• High risk: One or more “no” answers

• Unclear risk: Insufficient information

Applicability ratings focus on whether the test or population matches your clinical question. For example, a study of ultrasound in tertiary ICUs may not apply to primary care.

---

❗ What QUADAS-2 Does Not Do

• It does not produce a summary score—because different domains affect bias differently.

• It is not a substitute for understanding study design logic.

• It should be used in conjunction with STARD (for reporting quality) and clinical judgment.

---

🧠 Key Takeaways

• QUADAS-2 helps identify methodological weaknesses in diagnostic accuracy studies across four domains.

• It is not a numeric score—but a structured, domain-based evaluation.

• Common biases caught by QUADAS-2 include:

  • Spectrum bias

  • Partial verification bias

  • Review bias

  • Overfitting from post hoc thresholds

• Each domain requires tailoring based on the clinical context and review objective.